Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Rheumatology (Oxford, England)
|
January 3, 2012
Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator
Lorne A Clarke
Expert Reviews in Molecular Medicine
|
January 19, 2008
The mucopolysaccharidoses: a success of molecular medicine
Lorne A Clarke
Expert Review of Endocrinology & Metabolism
|
February 21, 2019
Laronidase for the treatment of mucopolysaccharidosis type I
Lorne A Clarke
Expert Opinion on Pharmacotherapy
|
January 19, 2008
Idursulfase for the treatment of mucopolysaccharidosis II
Lorne A Clarke
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 20, 2015
The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders
Lorne A Clarke, Carla E M Hollak
Pediatrics
|
January 2, 2009
Mucopolysaccharidosis I: management and treatment guidelines
Joseph Muenzer, James E Wraith, Lorne A Clarke, et al.
Molecular Genetics and Metabolism
|
November 21, 2014
Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I
Jonathan M Heppner, Frank Zaucke, Lorne A Clarke
Molecular Genetics and Metabolism
|
February 16, 2016
Implementing evidence-driven individualized treatment plans within Morquio A Syndrome
Lorne A Clarke, Paul Harmatz, Edward W Fong
Molecular Genetics and Metabolism
|
May 3, 2005
A homology model for human alpha-l-iduronidase: insights into human disease
Brian P Rempel, Lorne A Clarke, Stephen G Withers
Molecular Genetics and Metabolism
|
June 27, 2012
Left ventricular aneurysm in an adult patient with mucopolysaccharidosis type I: comment on pathogenesis of a novel complication
Gustavo H Cabrera, Isabel Fernández, Marcelo Dominguez, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Rheumatology (Oxford, England)
|
January 3, 2012
Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator
Lorne A Clarke
Expert Reviews in Molecular Medicine
|
January 19, 2008
The mucopolysaccharidoses: a success of molecular medicine
Lorne A Clarke
Expert Review of Endocrinology & Metabolism
|
February 21, 2019
Laronidase for the treatment of mucopolysaccharidosis type I
Lorne A Clarke
Expert Opinion on Pharmacotherapy
|
January 19, 2008
Idursulfase for the treatment of mucopolysaccharidosis II
Lorne A Clarke
Best Practice & Research. Clinical Endocrinology & Metabolism
|
May 20, 2015
The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders
Lorne A Clarke, Carla E M Hollak
Pediatrics
|
January 2, 2009
Mucopolysaccharidosis I: management and treatment guidelines
Joseph Muenzer, James E Wraith, Lorne A Clarke, et al.
Molecular Genetics and Metabolism
|
November 21, 2014
Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I
Jonathan M Heppner, Frank Zaucke, Lorne A Clarke
Molecular Genetics and Metabolism
|
February 16, 2016
Implementing evidence-driven individualized treatment plans within Morquio A Syndrome
Lorne A Clarke, Paul Harmatz, Edward W Fong
Molecular Genetics and Metabolism
|
May 3, 2005
A homology model for human alpha-l-iduronidase: insights into human disease
Brian P Rempel, Lorne A Clarke, Stephen G Withers
Molecular Genetics and Metabolism
|
June 27, 2012
Left ventricular aneurysm in an adult patient with mucopolysaccharidosis type I: comment on pathogenesis of a novel complication
Gustavo H Cabrera, Isabel Fernández, Marcelo Dominguez, et al.
Page
of 5